Navigation Links
New model of skin cancer provides insights on second-most common type of cancer
Date:12/10/2009

PHILADELPHIA Scientists at the University of Pennsylvania School of Medicine have developed a new model of skin cancer based on the knowledge that a common cancer-related molecule called Src kinase is activated in human skin-cancer samples.

"Our previous work demonstrated that Src kinases are activated in human squamous cell carcinomas of the skin. We modeled these observations by increasing the expression of the gene Fyn, a member of Src family of proteins, in mouse skin," explains senior author John T. Seykora M.D., Ph.D, assistant professor of Dermatology. In addition, prior work by the Seykora lab on a related protein called Srcasm, discovered by him in 2002, suggested that Srcasm may function as an anti-oncogene, a molecule that keeps others in check in order to control cell growth.

In this proof-of-principle study, published this month in Cancer Research, the authors found that genetically engineered mice expressing a K14-Fyn transgene develop precancerous lesions and invasive squamous cell carcinomas (SCCs) spontaneously in 5 to 8 weeks. Skin SCCs are the second most common form of cancer, with greater than 250,000 cases annually in the US, leading to approximately 2,500 deaths.

This study demonstrates that Fyn is a potent oncogene in skin. When Srcasm levels are raised in the mouse skin cancer model, tumor formation is dramatically inhibited showing that Srcasm functions as an anti-oncogene.

The findings highlight an important relationship between Fyn and SrcasmFyn encourages growth, while Srcasm inhibits it. "When this system malfunctions, it's like stepping on the gas and taking off the brakes on cell growth," explains Seykora. "Adding Srcasm back to the system lowers Fyn levels and restores order."

Analysis of human skin tumor samples confirmed that Srcasm levels are decreased and Src kinase activity is increased. The authors conclude that one potential means of combating skin cancer would be to inhibit Src kinases and/or increase Srcasm levels.

This work may have broader relevance as Src kinases are one of the longest studied oncogenes and are activated in many types of human cancer, including colon and breast cancer. This study provides insight into how Src kinases are activated in human cancers. Further study of this model may provide insights into treating carcinomas that have increased Src kinase activity

Future work will involve determining how Srcasm levels are decreased in skin tumors to promote cell growth. In addition, topical compounds will be tested using this model to determine if they may be useful in treating skin cancer in people.


'/>"/>

Contact: Karen Kreeger
karen.kreeger@uphs.upenn.edu
215-349-5658
University of Pennsylvania School of Medicine
Source:Eurekalert  

Related medicine news :

1. Measuring and modeling blood flow in malaria
2. Massachusetts Model Tobacco Cessation Benefit Spurs Unprecedented Drop in Smoking Rates, Heart Attacks, Asthma, and Birth Complications
3. New Series of Podcasts Highlight Supermodel's "Life-altering" Experience to Raise Awareness of Fibroid Treatment Options
4. Drexel Universitys Eleventh Street Health Services Recognized as National Model of Innovative Health Care
5. Health Integrated Announces Turnkey Model of Care Program for Special Needs Health Plans
6. Dramatic Settlement Sets National Model for H1N1 Hospital Safety Measures
7. NovaBays Aganocides Show Penetration and Efficacy in a Pre-Clinical Infected Human Nail Model of Onychomycosis
8. Pittsburgh Partners Launch Promising Family-Centered Care Model: Special Focus on Promoting Parental Well-Being and Healthy Child Development
9. UC San Diego researchers reverse pulmonary arterial hypertension in mouse models
10. General anesthetics lead to learning disabilities in animal models
11. New mathematical model more accurately diagnoses acute heart failure in emergency rooms
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
New model of skin cancer provides insights on second-most common type of cancer
(Date:3/22/2017)... ... March 23, 2017 , ... ... development solutions for drugs, biologics and consumer health products, today announced that it ... Convention, currently taking place at the Suntec Singapore International Exhibition & Convention Centre, ...
(Date:3/22/2017)... CA (PRWEB) , ... March 22, 2017 , ... ... Jose, Santa Cruz and Milpitas with a robust, ongoing community enrichment program, has ... (FSH), a nonprofit organization which has provided for the critical needs of homeless ...
(Date:3/22/2017)... California (PRWEB) , ... March 22, 2017 , ... Old ... British boxing champ Ashley Theophane as a new Brand Ambassador. Theophane, who trained with ... light welterweight title in 2011. He has racked up an impressive number of wins ...
(Date:3/22/2017)... CA (PRWEB) , ... March 22, 2017 , ... ... recovery agency for northern California and Nevada and LABS, Inc., announced the future ... turnaround (STAT) infectious disease screening and serology testing used to determine the ...
(Date:3/22/2017)... ... March 22, 2017 , ... Wash Tower Ltd. has released a ... the Wash Tower, the world's first standalone constant pressure bidet. , The videos in ... website at https://www.washtower.com as well as on its social media pages. , ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... YORK , March 22, 2017 FinancialBuzz.com ... According ... market was worth an estimated $6.6 billion in 2016, and is ... 16% or reaching more than $24 billion by 2025. The medical ... or growing from $4.7 billion in 2016, to an estimated $13.3 ...
(Date:3/22/2017)... Sweden , March 22, 2017 TFS ... and Mr. Ed Tumaian , two global executive positions ... will be joining the Operational Leadership Team and will report to ... ... comes to TFS with 10 years of medical and scientific ...
(Date:3/22/2017)... 22, 2017  As the world,s leading non-profit dedicated ... (LLS) has played a role in most therapies used ... are even helping patients with other cancers and serious ... investment in cutting-edge research – more than $1 billion ... with the record-breaking sum of $4.1 million raised at ...
Breaking Medicine Technology: